Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "vaccines" return 81 results.
Ceva plans many activities at IPPE 2017 >
Ceva Animal Health has planned a number of activities for attendees at the International Production and Processing Exposition (IPPE) taking place this week in Atlanta.
C.H.I.C.K Program receives world’s first quality recognition from Bureau Veritas >
Ceva Santé Animale is proud to announce that for the first time, a services program delivered by an animal health company has received internationally recognized, quality approval.
Industry Veteran Joins Swine Team >
Wes Johnson named strategic account manager
Ceva Names Custom Vaccines Marketing Manager >
David Hankins Brings Strong Background to Swine and Poultry Businesses
Ceva Is Growing >
Ceva Animal Health is set on becoming a major player in the swine industry within the next five years.
Experts from Around the World Gather to Discuss the Global Threat of Avian Influenza >
The meeting sought to understand the continuing threat posed by AI and the value of vaccination in changing times.
Ceva Animal Health Receives Contract to Provide Avian Influenza Vaccine for USDA stockpile >
Ceva receives contract to produce avian influenza vaccine.
Ceva Biomune Breaks Ground on $20MM Expansion in Lenexa >
Ceva Biomune has broken ground on a new facility to meet demand for its vaccine products.
Ceva posts strong double-digit growth again in first half of 2015 >
Consolidated sales of the Ceva Group reached €424m at the end of June 2015, representing growth of 16% and +12% at constant perimeter and exchange rates.
Ceva Biomune Celebrates Completion of $10MM Expansion in Lenexa >
Ceva Biomune has again expanded facilities to meet demand for its vaccine products.